Literature DB >> 14706056

The concentrations of short-chain fatty acids and other microflora-associated characteristics in faeces from children with newly diagnosed Type 1 diabetes and control children and their family members.

U Samuelsson1, J Ludvigsson.   

Abstract

AIMS: The gut flora is quantitatively the most important source of microbial stimulation and may provide a primary signal in the maturation of the immune system. We compared the microflora-associated characteristics (MACs) in 22 children with newly diagnosed diabetes, 27 healthy controls, and their family members to see if there were differences between the children and if there was a familial pattern.
METHODS: The MACs were assessed by determining the concentrations of eight short-chain fatty acids (SCFA), mucin, urobilin, b-aspartylglycine, coprastanol and faecal tryptic activity (FTA).
RESULTS: There were no statistically significant differences between the concentrations of SCFA in the diabetes and control children. Members of families with a diabetic child had a higher concentration of acetic acid (P < 0.02) and lower concentrations of several other SCFAs than control families (P < 0.05-0.02). The other MACs showed no differences between the children or between the two family groups.
CONCLUSION: In this pilot study we saw no differences in the MACs between children with diabetes and their controls. There were, however, some differences between the family members of diabetic children and controls that may indicate a familial pattern regarding the production of SCFAs by the gut flora. The role of the gut flora in relation to the risk of developing Type 1 diabetes needs to be analysed in larger and/or prospective studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14706056     DOI: 10.1046/j.1464-5491.2003.01066.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  6 in total

1.  Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial.

Authors:  Pieter F de Groot; Tatjana Nikolic; Sultan Imangaliyev; Siroon Bekkering; Gaby Duinkerken; Fleur M Keij; Hilde Herrema; Maaike Winkelmeijer; Jeffrey Kroon; Evgeni Levin; Barbara Hutten; Elles M Kemper; Suat Simsek; Johannes H M Levels; Flora A van Hoorn; Renuka Bindraban; Alicia Berkvens; Geesje M Dallinga-Thie; Mark Davids; Frits Holleman; Joost B L Hoekstra; Erik S G Stroes; Mihai Netea; Daniël H van Raalte; Bart O Roep; Max Nieuwdorp
Journal:  Diabetologia       Date:  2020-01-08       Impact factor: 10.122

2.  Short-chain fatty acids exert opposite effects on the expression and function of p-glycoprotein and breast cancer resistance protein in rat intestine.

Authors:  Qiu-Shi Xie; Jia-Xin Zhang; Ming Liu; Pei-Hua Liu; Zhong-Jian Wang; Liang Zhu; Ling Jiang; Meng-Meng Jin; Xiao-Nan Liu; Li Liu; Xiao-Dong Liu
Journal:  Acta Pharmacol Sin       Date:  2020-06-17       Impact factor: 6.150

Review 3.  The pancreas in human type 1 diabetes.

Authors:  Patrick A Rowe; Martha L Campbell-Thompson; Desmond A Schatz; Mark A Atkinson
Journal:  Semin Immunopathol       Date:  2010-05-22       Impact factor: 9.623

Review 4.  Towards microbial fermentation metabolites as markers for health benefits of prebiotics.

Authors:  Kristin A Verbeke; Alan R Boobis; Alessandro Chiodini; Christine A Edwards; Anne Franck; Michiel Kleerebezem; Arjen Nauta; Jeroen Raes; Eric A F van Tol; Kieran M Tuohy
Journal:  Nutr Res Rev       Date:  2015-06       Impact factor: 7.800

5.  Genomic reconstruction of short-chain fatty acid production by the human gut microbiota.

Authors:  Maria S Frolova; Inna A Suvorova; Stanislav N Iablokov; Sergei N Petrov; Dmitry A Rodionov
Journal:  Front Mol Biosci       Date:  2022-08-11

6.  Butyrate induced Tregs are capable of migration from the GALT to the pancreas to restore immunological tolerance during type-1 diabetes.

Authors:  Neenu Jacob; Shivani Jaiswal; Deep Maheshwari; Nayudu Nallabelli; Neeraj Khatri; Alka Bhatia; Amanjit Bal; Vivek Malik; Savita Verma; Rakesh Kumar; Naresh Sachdeva
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.